Anemia and mortality in heart failure patients a systematic review and meta-analysis.

[1]  D. Dorr,et al.  Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. , 2008, JAMA.

[2]  Anil K. Jain,et al.  Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. , 2008, Journal of the American College of Cardiology.

[3]  P. Armstrong,et al.  Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia , 2008, Circulation.

[4]  P. Ponikowski,et al.  Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2007, Journal of the American College of Cardiology.

[5]  M. Kruszewski,et al.  Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. , 2008, European heart journal.

[6]  P. Ponikowski,et al.  Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. , 2008, European heart journal.

[7]  P. Hildebrandt,et al.  Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure. , 2007, The American journal of cardiology.

[8]  P. Duarte,et al.  Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. , 2007, Journal of the American College of Cardiology.

[9]  C. R. M. R. Sobrinho,et al.  Prevalance of anemia and its association with cardio-renal syndrome. , 2007, International journal of cardiology.

[10]  J. McMurray,et al.  Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial , 2007, European journal of heart failure.

[11]  D. Silverberg,et al.  Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. , 2006, American heart journal.

[12]  H. Burger,et al.  Normalization of hemoglobin level in patients with chronic kidney disease and anemia. , 2006, The New England journal of medicine.

[13]  Huiman Barnhart,et al.  Correction of anemia with epoetin alfa in chronic kidney disease. , 2006, The New England journal of medicine.

[14]  P. Varadarajan,et al.  Prognostic significance of hemoglobin level in patients with congestive heart failure and normal ejection fraction , 2006, Clinical cardiology.

[15]  M. Fraser,et al.  Prevalence and clinical implications of anemia in congestive heart failure patients followed at a specialized heart function clinic. , 2006, Congestive heart failure.

[16]  M. Cesari,et al.  Anemia, physical disability, and survival in older patients with heart failure. , 2006, Journal of cardiac failure.

[17]  S. Solomon,et al.  Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF)™ Trial , 2006 .

[18]  A. Rigby,et al.  Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. , 2006, The American journal of cardiology.

[19]  A. Go,et al.  Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study , 2006, Circulation.

[20]  J. McMurray,et al.  The prevalence, nature, and importance of hematologic abnormalities in heart failure. , 2006, American heart journal.

[21]  P. Poole‐Wilson,et al.  The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. , 2006, European heart journal.

[22]  Harlan M Krumholz,et al.  Renal impairment and outcomes in heart failure: systematic review and meta-analysis. , 2006, Journal of the American College of Cardiology.

[23]  O. Castañer,et al.  Anemia in new-onset congestive heart failure inpatients admitted for acute decompensation. , 2006, European journal of internal medicine.

[24]  J. Newton,et al.  Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure , 2006, Heart.

[25]  M. Anastasiou-Nana,et al.  Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  L. Stevenson,et al.  The effect of anemia on mortality in indigent patients with mild-to-moderate chronic heart failure. , 2006, Congestive heart failure.

[27]  P. Ponikowski,et al.  Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa on hemoglobin response and symptoms in patients with heart failure and anemia , 2006 .

[28]  S. Solomon,et al.  Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program , 2006, Circulation.

[29]  C. O'connor,et al.  Anemia in patients with heart failure and preserved systolic function. , 2006, American heart journal.

[30]  M. Fraser,et al.  Prevalence and clinical implications of anemia in congestive heart failure patients followed at a specialized heart function clinic. , 2006, Congestive heart failure.

[31]  G. Fonarow,et al.  Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure. , 2005, American heart journal.

[32]  H. Krumholz,et al.  Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. , 2005, Archives of internal medicine.

[33]  J. González-Juanatey,et al.  Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function , 2005, Heart.

[34]  Cristina Opasich,et al.  Anemia and Change in Hemoglobin Over Time Related to Mortality and Morbidity in Patients With Chronic Heart Failure: Results From Val-HeFT , 2005, Circulation.

[35]  O. Topolcan,et al.  Short to long term mortality of patients hospitalised with heart failure in the Czech Republic—a report from the EuroHeart Failure Survey , 2005, European journal of heart failure.

[36]  T. McDonagh,et al.  N-terminal brain natriuretic peptide, but not anemia, is a powerful predictor of mortality in advanced heart failure. , 2005, Journal of cardiac failure.

[37]  L. Tavazzi,et al.  Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice. , 2005, Journal of cardiac failure.

[38]  P. Armstrong,et al.  The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic. , 2005, The Canadian journal of cardiology.

[39]  R. Foley.  Myocardial disease, anemia, and erythrocyte-stimulating proteins in chronic kidney disease. , 2005, Reviews in cardiovascular medicine.

[40]  P. Poole‐Wilson,et al.  Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. , 2004, European heart journal.

[41]  A. Burger,et al.  Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. , 2004, The American journal of cardiology.

[42]  J. McMurray,et al.  Anemia and Its Relationship to Clinical Outcome in Heart Failure , 2004, Circulation.

[43]  A. Voors,et al.  Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. , 2004, Journal of the American College of Cardiology.

[44]  A. Voors,et al.  Erythropoietin in cardiovascular diseases. , 2004, European heart journal.

[45]  P. Ponikowski,et al.  Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. , 2003, International journal of cardiology.

[46]  K. Freedland,et al.  Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction. , 2003, American heart journal.

[47]  P. Poole‐Wilson,et al.  Haemoglobin concentration and prognosis in new cases of heart failure , 2003, The Lancet.

[48]  D. Mozaffarian,et al.  Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). , 2003, Journal of the American College of Cardiology.

[49]  Harlan M Krumholz,et al.  The prognostic importance of anemia in patients with heart failure. , 2003, The American journal of medicine.

[50]  Paul W Armstrong,et al.  Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[51]  D. Silverberg,et al.  The importance of anemia and its correction in the management of severe congestive heart failure , 2002, European journal of heart failure.

[52]  O. Hess,et al.  The prevalence of anemia in chronic heart failure. , 2002, International journal of cardiology.

[53]  C. Jurkovitz,et al.  Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. , 2002, Journal of the American Society of Nephrology : JASN.

[54]  G. Fonarow,et al.  Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. , 2002, Journal of the American College of Cardiology.

[55]  L. Ruilope,et al.  Renal function: the Cinderella of cardiovascular risk profile. , 2001, Journal of the American College of Cardiology.

[56]  W. Rand,et al.  Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.

[57]  Douglas G Altman,et al.  Systematic reviews of evaluations of prognostic variables , 2001, BMJ : British Medical Journal.

[58]  I. Shapira,et al.  The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. , 2001, Journal of the American College of Cardiology.

[59]  C. Mulrow,et al.  Current methods of the US Preventive Services Task Force: a review of the process. , 2001, American journal of preventive medicine.

[60]  P. Ubel,et al.  Barriers to influenza immunization in a low-income urban population. , 2001, American journal of preventive medicine.

[61]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[62]  M. Domanski,et al.  The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. , 2000, Journal of the American College of Cardiology.

[63]  S. Yusuf,et al.  Strengths and limitations of meta-analysis: larger studies may be more reliable. , 1997, Controlled clinical trials.

[64]  R. Adolph,et al.  Cardiovascular effects of anemia. , 1972, American heart journal.